Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Howard E. Gendelman
Based on 21 articles published since 2008
||||
Expertise Level
The expertise of Howard E. Gendelman ranks in the
  • Top 0.7%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University of Nebraska System      
2017
  • Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA; Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Pubmed 28271041
2016
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Radiology, University of Nebraska Medical Center, Omaha, NE, USA. · Longevity Biotech, Philadelphia, PA, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 27329163
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: · Pubmed 26571205
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska. · Neurology Consultants of Nebraska, Omaha, Nebraska. · Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska. · Pubmed 27151624
2015
  • Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Pubmed 26520433
2014
  • Department of Psychology, University of Nebraska, Omaha, Nebraska; Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Physical Therapy, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Neurology Consultants of Nebraska, Omaha, Nebraska; · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska · Pubmed 25008416
2013
  • Department of Pharmaceutical Sciences, Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. · Pubmed 23620794
2012
  • Movement Disorders Program, Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA. · Pubmed 22315722
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 22166440
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 23054369
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22776646
2011
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22091596
  • Center for Drug Delivery & Nanomedicine, University of Nebraska, Omaha, NE, USA. · Pubmed 21449849
2010
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 20394532
2009
  • Center for Neurovirology and Neurodegenerative Disorders, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, USA. · Pubmed 19243239
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 68198, USA. · Pubmed 19299711
2008
  • Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 18202920
Possible:    Rush-Presbyterian St. Luke's Medical Center   Contact    
2012
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Pubmed 22723850
2009
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA. · Pubmed 19864567
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Howard E. Gendelman about Parkinson Disease:

  • The cortical signature of symptom laterality in Parkinson's disease. 2017
  • Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease. 2016
  • Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease. 2016
  • Quiet connections: Reduced fronto-temporal connectivity in nondemented Parkinson's Disease during working memory encoding. 2016
  • A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders. 2015
  • Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study. 2014
  • Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease. 2014
  • Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases. 2013
  • Inflammation and adaptive immunity in Parkinson's disease. 2012
  • Immunization strategies for Parkinson's disease. 2012
Show List of Full Article Records
Google Searches

Learn more about Howard E. Gendelman using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Nebraska System
Rush-Presbyterian St. Luke's Medical Center
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Nebraska System
2017
  • Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA; Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Pubmed 28271041
2016
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Radiology, University of Nebraska Medical Center, Omaha, NE, USA. · Longevity Biotech, Philadelphia, PA, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 27329163
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: · Pubmed 26571205
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska. · Neurology Consultants of Nebraska, Omaha, Nebraska. · Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska. · Pubmed 27151624
2015
  • Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Pubmed 26520433
2014
  • Department of Psychology, University of Nebraska, Omaha, Nebraska; Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Physical Therapy, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Neurology Consultants of Nebraska, Omaha, Nebraska; · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska · Pubmed 25008416
2013
  • Department of Pharmaceutical Sciences, Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. · Pubmed 23620794
2012
  • Movement Disorders Program, Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA. · Pubmed 22315722
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 22166440
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 23054369
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22776646
2011
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22091596
  • Center for Drug Delivery & Nanomedicine, University of Nebraska, Omaha, NE, USA. · Pubmed 21449849
2010
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 20394532
2009
  • Center for Neurovirology and Neurodegenerative Disorders, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, USA. · Pubmed 19243239
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 68198, USA. · Pubmed 19299711
2008
  • Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 18202920
Unspecified
2014
  • Department of Psychology, University of Nebraska, Omaha, NE, USA, Center for Magnetoencephalography. · Department of Pharmacology and Experimental Neuroscience, Department of Neurological Sciences, Center for Magnetoencephalography. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Neurological Sciences. · Department of Pharmacology and Experimental Neuroscience. · Department of Biostatistics, University of Nebraska Medical Center (UNMC), Omaha, NE, USA and. · Pubmed 23645717
Rush-Presbyterian St. Luke's Medical Center
2012
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Pubmed 22723850
2009
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA. · Pubmed 19864567
Yearly article counts 001312153131
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.